参考文献/References:
[1]Mohan C,Putterman C.Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis[J].Nat Rev Nephrol,2015,11(6):329-341.
[2]Christensen SR,Shupe J,Nickerson K,et al.Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus[J].Immunity,2006,25(3):417-428.
[3]Akatsu C,Shinagawa K,Numoto N,et al.CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP[J].J Exp Med,2016,213(12):2691-2706.
[4]Funabiki M,Kato H,Miyachi Y,et al.Autoimmune disorders associated with gain of function of the intracellular sensor MDA5[J].Immunity,2014,40(2):199-212.
[5]Christensen SR,Shupe J,Nickerson K,et al.Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus[J].Immunity,2006,25(3):417-428.
[6]Savarese E,Steinberg C,Pawar RD,et al.Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis[J].Arthritis Rheum,2008,58(4):1107-1115.
[7]Santiago-Raber ML,Dunand-Sauthier I,Wu T,et al.Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice[J].J Autoimmun,2010,34(4):339-348.
[8]Lau CM,Broughton C,Tabor AS,et al.RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement[J].J Exp Med,2005,202(9):1171-1177.
[9]Bennett L,Palucka AK,Arce E,et al.Interferon and granulopoiesis signatures in systemic lupus erythematosus blood[J].J Exp Med,2003,197(6):711-723.
[10]Baechler EC,Batliwalla FM,Karypis G,et al.Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus[J].Proc Natl Acad Sci USA,2003,100(5):2610-2615.
[11]Kiefer K,Oropallo MA,Cancro MP,et al.Role of type I interferons in the activation of autoreactive B cells[J].Immunol Cell Biol,2012,90(5):498-504.
[12]Teichmann LL,Schenten D,Medzhitov R,et al.Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus[J].Immunity,2013,38(3):528-540.
[13]Hnisz D,Abraham BJ,Lee TI,et al.Super-enhancers in the control of cell identity and disease[J].Cell,2013,155(4):934-947.
[14]Hu X,Kim H,Stahl E,et al.Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets[J].Am J Hum Genet,2011,89(4):496-506.
[15]Namjou B,Kothari PH,Kelly JA,et al.Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort[J].Genes Immun,2011,12(4):270-279.
[16]Beck-Engeser GB,Eilat D,Wabl M.An autoimmune disease prevented by anti-retroviral drugs[J].Retrovirology,2011(8):91.
[17]Gao D,Li T,Li XD,et al.Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases[J].Proc Natl Acad Sci USA,2015,112(42):E5699-E5705.
[18]Kato Y,Park J,Takamatsu H,et al.Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus[J].Ann Rheum Dis,2018,77(10):1507-1515.
[19]Adachi T,Flaswinkel H,Yakura H,et al.The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation[J].J Immunol,1998,160(10):4662-4665.
[20]Adachi T,Wakabayashi C,Nakayama T,et al.CD72 negatively regulates signaling through the antigen receptor of B cells[J].J Immunol,2000,164(3):1223-1229.
[21]Dustin LB,Plas DR,Wong J,et al.Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation[J].J Immunol,1999,162(5):2717-2724.
[22]Qu WM,Miyazaki T,Terada M,et al.Genetic dissection of vasculitis in MRL/lpr lupus mice:a novel susceptibility locus involving the CD72c allele[J].Eur J Immunol,2000,30(7):2027-2037.
[23]Watanabe-Fukunaga R,Brannan CI,Copeland NG,et al.Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis[J].Nature,1992,356(6367):314-317.
[24]Li DH,Winslow MM,Cao TM,et al.Modulation of peripheral B cell tolerance by CD72 in a murine model[J].Arthritis Rheum,2008,58(10):3192-3204.
[25]Xu M,Hou R,Sato-Hayashizaki A,et al.CD72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease[J].J Immunol,2013,190(11):5436-5445.
[26]朱太卿.吉兰-巴雷综合征患者B淋巴细胞辅助受体CD22、CD72表达的研究[D].中南大学,2009.
[27]Tsubata T.CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases:English version[J].Z Rheumatol,2017,76(Suppl 1):10-13.
[28]Pao LI,Lam KP,Henderson JM,et al.B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity[J].Immunity,2007,27(1):35-48.
[29]Lamagna C,Hu Y,DeFranco AL,et al.B cell-specific loss of Lyn kinase leads to autoimmunity[J].J Immunol,2014,192(3):919-928.
[30]Hoffmann A,Kerr S,Jellusova J,et al.Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population[J].Nat Immunol,2007,8(7):695-704.
[31]Jellusova J,Wellmann U,Amann K,et al.CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity[J].J Immunol,2010,184(7):3618-3627.
[32]Takai T,Nakamura A,Endo S.Role of PIR-B in autoimmune glomerulonephritis[J].J Biomed Biotechnol,2011(2011):275302.
[33]Wilkinson R,Lyons AB,Roberts D,et al.Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31)acts as a regulator of B-cell development, B-cell antigen receptor(BCR)-mediated activation,and autoimmune disease[J].Blood,2002,100(1):184-193.
[34]Brown MH,Lacey E.A ligand for CD5 is CD5[J].J Immunol,2010,185(10):6068-6074.
[35]Kumanogoh A,Watanabe C,Lee I,et al.Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100:a novel mechanism for regulating B cell signaling[J].Immunity,2000,13(5):621-631.
[36]Macauley MS,Crocker PR,Paulson JC.Siglec-mediated regulation of immune cell function in disease[J].Nat Rev Immunol,2014,14(10):653-666.
[37]Hutzler S,Ozgor L,Naito-Matsui Y,et al.The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells[J].J Immunol,2014,192(11):5406-5414.
[38]Vadasz Z,Goldeberg Y,Halasz K,et al.Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis[J].Clin Immunol,2016(164):114-118.
相似文献/References:
[1]吴 霞,肖盼盼,谢晓然,等.qRT-PCR法分析复发性SLE患者肠道双歧杆菌、
柔嫩梭菌数量的变化[J].医学信息,2018,31(05):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
WU Xia,XIAO Pan-pan,XIE Xiao-ran,et al.Analysis of the Changes of Intestinal Bifidobacterium and Clostridium Tenella in Patients with Recurrent SLE by qRT-PCR[J].Journal of Medical Information,2018,31(14):65.[doi:10.3969/j.issn.1006-1959.2018.05.022]
[2]陈汉白,赵之婧,罗希莹,等.系统性红斑狼疮治疗领域文献的大数据分析[J].医学信息,2019,32(23):1.[doi:10.3969/j.issn.1006-1959.2019.23.001]
CHEN Han-bai,ZHAO Zhi-jing,LUO Xi-ying,et al.Big Data Analysis of Literature in the Field of Systemic Lupus Erythematosus Treatment[J].Journal of Medical Information,2019,32(14):1.[doi:10.3969/j.issn.1006-1959.2019.23.001]
[3]白巧红.系统性红斑狼疮合并感染的临床特点[J].医学信息,2019,32(23):86.[doi:10.3969/j.issn.1006-1959.2019.23.023]
BAI Qiao-hong.Clinical Features of Systemic Lupus Erythematosus Infection[J].Journal of Medical Information,2019,32(14):86.[doi:10.3969/j.issn.1006-1959.2019.23.023]
[4]王 娟,汪 奎,牛彩琴.贝利木单抗治疗系统性红斑狼疮的有效性和安全性的系统评价[J].医学信息,2021,34(21):65.[doi:10.3969/j.issn.1006-1959.2021.21.016]
WANG Juan,WANG Kui,NIU Cai-qin.System Analysis of the Efficacy and Safety of Belimumab in the Treatment of Systemic Lupus Erythematosus[J].Journal of Medical Information,2021,34(14):65.[doi:10.3969/j.issn.1006-1959.2021.21.016]
[5]徐 莹,薛国辉,华 琳.系统性红斑狼疮患者中TAFI、PAI-1及t-PA水平变化及其与疾病活动度的关系[J].医学信息,2020,33(20):54.[doi:10.3969/j.issn.1006-1959.2020.20.015]
XU Ying,XUE Guo-hui,HUA Lin.Changes of TAFI,PAI-1 and t-PA Levels in Patients with Systemic Lupus Erythematosus and Their Relationship with Disease Activity[J].Journal of Medical Information,2020,33(14):54.[doi:10.3969/j.issn.1006-1959.2020.20.015]
[6]皮玲玲.基于Medline数据库的国内风湿病发表论文的可视化分析[J].医学信息,2022,35(03):13.[doi:10.3969/j.issn.1006-1959.2022.03.003]
PI Ling-ling.Visual Analysis of Published Papers on Rheumatism in China Based on Medline Database[J].Journal of Medical Information,2022,35(14):13.[doi:10.3969/j.issn.1006-1959.2022.03.003]
[7]卢 慧,钱 龙.淋巴细胞亚群与系统性红斑狼疮患者发生感染的相关性[J].医学信息,2022,35(04):111.[doi:10.3969/j.issn.1006-1959.2022.04.027]
LU Hui,QIAN Long.Correlation Between Lymphocyte Subsets and Infection in Patientswith Systemic Lupus Erythematosus[J].Journal of Medical Information,2022,35(14):111.[doi:10.3969/j.issn.1006-1959.2022.04.027]